Early antipsychotic treatment in juvenile rats elicits long-term alterations to the adult serotonin receptors

References

• AlexanderGCGallagherSAMascolaAMoloneyRMStaffordRSIncreasing off-label use of antipsychotic Medications in the United StatesPharmacoepidemiol Drug Saf201120217718421254289
   PubMed Web of Science ®Google Scholar
• SeidaJCSchoutenJRBoylanKAntipsychotics for children and young adults: a comparative effectiveness reviewPediatrics20121293e771e78422351885
   PubMed Web of Science ®Google Scholar
• OlfsonMBlancoCLiuSWangSCorrellCUNational trends in the office-based treatment of children, adolescents, and adults with antipsychoticsArch Gen Psychiatry201269121247125622868273
   PubMed Web of Science ®Google Scholar
• RaniFMurrayMLByrnePJWongICKEpidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United KingdomPediatrics200812151002100918450906
   PubMed Web of Science ®Google Scholar
• OlfsonMCrystalSHuangCGerhardTTrends in antipsychotic drug use by very young, privately insured childrenJ Am Acad Child Adolesc Psychiatry2010491132320215922
   PubMed Web of Science ®Google Scholar
• VarleyCKMcClellanJImplications of marked weight gain associated with atypical antipsychotic medications in children and adolescentsJAMA2009302161811181219861677
   PubMed Web of Science ®Google Scholar
• HoekstraPJRisperidone for non-psychotic disorders in paediatric patients: which child is to benefit?Dev Med Child Neurol20145610919920
   Web of Science ®Google Scholar
• AndersenSLNavaltaCPAltering the course of neurodevelopment: a framework for understanding the enduring effects of psychotropic drugsInt J Dev Neurosci2004225–642344015380841
   PubMed Web of Science ®Google Scholar
• MemarziaJTracyDGiaroliGThe use of antipsychotics in preschoolers: a veto or a sensible last option?J Psychopharmacol201428430331924451556
   PubMed Web of Science ®Google Scholar
• MoeAAKScottJGBurneTHJEylesDWNeural changes induced by antipsychotic administration in adolescence: a review of studies in laboratory rodentsJ Psychopharmacol201630877179427413140
   PubMed Web of Science ®Google Scholar
• MaddenCBlackBWillsieDTreating our youngest patients: psychotropic medications in early childhoodMo Med2014111320721125011342
   PubMedGoogle Scholar
• SchneiderCTaylorDZalsmanGFrangouSKyriakopoulosMAntipsychotics use in children and adolescents: an on-going challenge in clinical practiceJ Psychopharmacol201428761562324902872
   PubMed Web of Science ®Google Scholar
• HawCStubbsJOff-label use of antipsychotics: are we mad?Expert Opin Drug Saf20076553354517877441
   PubMed Web of Science ®Google Scholar
• VitielloBCorrellCvan Zwieten-BootBZuddasAParelladaMArangoCAntipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concernsEur Neuropsychopharmacol200919962963519467582
   PubMed Web of Science ®Google Scholar
• SharmaAShawSREfficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: a meta-analysisJ Pediatr Health Care201226429129922726714
   PubMed Web of Science ®Google Scholar
• GraceAAFlorescoSBGotoYLodgeDJRegulation of firing of dopaminergic neurons and control of goal-directed behaviorsTrends Neurosci200730522022717400299
   PubMed Web of Science ®Google Scholar
• KegelesLSAbi-DarghamAFrankleWGIncreased synaptic dopamine function in associative regions of the striatum in schizophreniaArch Gen Psychiatry201067323123920194823
   PubMed Web of Science ®Google Scholar
• Purves-TysonTDHandelsmanDJDoubleKLOwensSJBustamanteSWeickertCSTestosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigraBMC Neurosci20121319522867132
   PubMed Web of Science ®Google Scholar
• MilsteinJAElnabawiAVinishMOlanzapine treatment of adolescent rats causes enduring specific memory impairments and alters cortical development and functionPLoS One201382e5730823437365
   PubMed Web of Science ®Google Scholar
• MeltzerHYMechanism of action of atypical antipsychotic drugsDavisKLCharneyDCoyleJTNemeroffCNeuropsychopharmacology: The Fifth Generation of ProgressNashville, TNAmerican College of Neuropsychopharmacology2002819831
   Google Scholar
• NasrallahHAAtypical antipsychotic-induced metabolic side effects: insights from receptor-binding profilesMol Psychiatry2008131273517848919
   PubMed Web of Science ®Google Scholar
• AmatoDSerotonin in antipsychotic drugs actionBehav Brain Res201527712513525078293
   PubMed Web of Science ®Google Scholar
• LevittPHarveyJAFriedmanESimanskyKMurphyEHNew evidence for neurotransmitter influences on brain developmentTrends Neurosci19972062692749185309
   PubMed Web of Science ®Google Scholar
• FrostDOCadetJLEffects of methamphetamine-induced neurotoxicity on the development of neural circuitry: a hypothesisBrain Res Rev200034310311811113502
   PubMedGoogle Scholar
• KlompATremoledaJLWylezinskaMLasting effects of chronic fluoxetine treatment on the late developing rat brain: age-dependent changes in the serotonergic neurotransmitter system assessed by pharmacological MRINeuroimage201259121822621840402
   PubMed Web of Science ®Google Scholar
• AndersenSLTrajectories of brain development: point of vulnerability or window of opportunity?Neurosci Biobehav Rev2003271–231812732219
   PubMed Web of Science ®Google Scholar
• MarcoEMAdrianiWRuoccoLACaneseRSadileAGLaviolaGNeurobehavioral adaptations to methylphenidate: the issue of early adolescent exposureNeurosci Biobehav Rev20113581722173921376076
   PubMed Web of Science ®Google Scholar
• CousinsLGoodyerIMAntidepressants and the adolescent brainJ Psychopharmacol201529554555525744620
   PubMed Web of Science ®Google Scholar
• PiontkewitzYAradMWeinerITracing the development of psychosis and its prevention: what can be learned from animal modelsNeuropharmacology20126231273128921703648
   PubMed Web of Science ®Google Scholar
• DiefenbachTJSloleyBDGoldbergJINeurite branch development of an identified serotonergic neuron from embryonic helisoma: evidence for autoregulation by serotoninDev Biol199516712822937851649
   PubMed Web of Science ®Google Scholar
• DinopoulosADoriIParnavelasJGThe serotonin innervation of the basal forebrain shows a transient phase during developmentBrain Res Dev Brain Res199799138529088564
   PubMedGoogle Scholar
• Whitaker-AzmitiaPMSerotonin and brain development: role in human developmental diseasesBrain Res Bull200156547948511750793
   PubMed Web of Science ®Google Scholar
• SongNNZhangQHuangYChenLDingYQZhangLEnhanced dendritic morphogenesis of adult hippocampal newborn neurons in central 5-HT-deficient miceStem Cell Res20171961128012347
   PubMed Web of Science ®Google Scholar
• BottelierMASchouwMLJKlompAThe effects of Psychotropic Drugs On Developing Brain (ePOD) study: methods and designBMC Psychiatry20141414824552282
   PubMed Web of Science ®Google Scholar
• De SantisMLianJHuangXFDengCEarly antipsychotic treatment in juvenile rats elicits long-term alterations to the dopamine neurotransmitter systemInt J Mol Sci201617111944
   Web of Science ®Google Scholar
• SeoDPatrickCJKennealyPJRole of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disordersAggress Violent Behav200813538339519802333
   PubMed Web of Science ®Google Scholar
• KusljicSCopolovDLvan den BuuseMDifferential role of serotonergic projections arising from the dorsal and median raphe nuclei in locomotor hyperactivity and prepulse inhibitionNeuropsychopharmacology200328122138214712888784
   PubMed Web of Science ®Google Scholar
• KapurSRemingtonGSerotonin-dopamine interaction and its relevance to schizophreniaAm J Psychiatry199615344664768599393
   PubMed Web of Science ®Google Scholar
• De SantisMLianJHuangXFDengCEarly antipsychotic treatment in childhood/adolescent period has long-term effects on depressive-like, anxiety-like and locomotor behaviours in adult ratsJ Psychopharmacol201630220421426577063
   PubMed Web of Science ®Google Scholar
• KumraSOberstarJVSikichLEfficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophreniaSchizophr Bull2008341607117923452
   PubMed Web of Science ®Google Scholar
• StiglerKAMcDougleCJPoseyDJPotenzaMNWeight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and managementPediatr Drugs2004613344
   PubMedGoogle Scholar
• ZuddasAZanniRUsalaTSecond generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studiesEur Neuropsychopharmacol201121860062021550212
   PubMed Web of Science ®Google Scholar
• ShuQHuGLiMAdult response to olanzapine or clozapine treatment is altered by adolescent antipsychotic exposure: a preclinical test in the phencyclidine hyperlocomotion modelJ Psychopharmacol201428436337524257809
   PubMed Web of Science ®Google Scholar
• VarelaFADer-GhazarianTLeeRJCharntikovSCrawfordCAMcDougallSARepeated aripiprazole treatment causes dopamine D2 receptor up-regulation and dopamine supersensitivity in young ratsJ Psychopharmacol201428437638624045880
   PubMed Web of Science ®Google Scholar
• LianJPanBDengCEarly antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile ratsPharmacol Rep20166851028103527428765
   PubMed Web of Science ®Google Scholar
• ChoiYKMoran-GatesTGardnerMPTaraziFIEffects of repeated risperidone exposure on serotonin receptor subtypes in developing ratsEur Neuropsychopharmacol201020318719419875272
   PubMed Web of Science ®Google Scholar
• Moran-GatesTGanLParkYSZhangKBaldessariniRJTaraziFIRepeated antipsychotic drug exposurein developing rats: dopamine receptor effectsSynapse20065929210016270300
   PubMed Web of Science ®Google Scholar
• VinishMElnabawiAMilsteinJAOlanzapine treatment of adolescent rats alters adult reward behavior and nucleus accumbens functionInt J Neuropsychopharmacol201216715991609
   Web of Science ®Google Scholar
• TaylorDPatonCKapurSMaudsley Prescribing Guidelines10 edNew YorkInforma Healthcare2009
   Google Scholar
• AravagiriMMarderSRBrain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to ratsPsychopharmacology2002159442443111823895
   PubMed Web of Science ®Google Scholar
• Reagan-ShawSNihalMAhmadNDose translation from animal to human studies revisitedFASEB J200822365966117942826
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER)2005Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers Available from: https://www.fda.gov/downloads/drugs/guidances/ucm078932.pdfAccessed February 2, 2018
   Google Scholar
• WadenbergMLGBifeprunox: a novel antipsychotic agent with partial agonist properties at dopamine D2 and serotonin 5-HT1A receptorsFuture Neurol200722153165
   Google Scholar
• KapurSVanderSpekSCBrownleeBANobregaJNAntipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancyJ Pharmacol Exp Ther2003305262563112606608
   PubMed Web of Science ®Google Scholar
• NatesanSRecklessGENobregaJNFletcherPJKapurSDissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal modelsNeuropsychopharmacology20063191854186316319908
   PubMed Web of Science ®Google Scholar
• LianJDe SantisMHeMDengCRisperidone-induced weight gain and reduced locomotor activity in juvenile female rats: the role of histaminergic and NPY pathwaysPharmacol Res201595–962026
   PubMed Web of Science ®Google Scholar
• HeMZhangQDengCWangHLianJHuangXFHypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female ratsPsychoneuroendocrinology20144215316424636512
   PubMed Web of Science ®Google Scholar
• ZhangQLianJHeMDengCWangHHuangXFOlanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female ratsProg Neuropsychopharmacol Biol Psychiatry20145117218024548587
   PubMed Web of Science ®Google Scholar
• ZhangQHeMDengCWangHLianJHuangXFHypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female ratsInt J Neuropsychopharmacol201417580781824468236
   PubMed Web of Science ®Google Scholar
• DengCPanBHuCHHanMHuangXFDifferential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brainPsychiatry Res2015225334735425576368
   PubMed Web of Science ®Google Scholar
• IslamMRMoriguchiSTagashiraHFukunagaKRivastigmine restores 5-HT 1A receptor levels in the hippocampus of olfactory bulbectomized miceAdv Alzheimer’s Dis201433128136
   Google Scholar
• PavoneLMSpinaAReaSSerotonin transporter gene deficiency is associated with sudden death of newborn mice through activation of TGF-β1 signallingJ Mol Cell Cardiol200947569169719646988
   PubMed Web of Science ®Google Scholar
• Sheikhkanloui-MilanHSheibaniVAfarineshMEsmaeili-MahaniSShamsizadehASepehriGEffects of electrical stimulation of dorsal raphe nucleus on neuronal response properties of barrel cortex layer IV neurons following long-term sensory deprivationNeurosci Bull201026538839420882065
   PubMed Web of Science ®Google Scholar
• LiuSBubarMJLanfrancoMFHillmanGRCunninghamKASerotonin 2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addictionNeuroscience200714641677168817467185
   PubMed Web of Science ®Google Scholar
• HanMHuangXFdu BoisTMDengCThe effects of antipsychotic drugs administration on 5-HT1A receptor expression in the limbic system of the rat brainNeuroscience200916441754176319778583
   PubMed Web of Science ®Google Scholar
• LianJHuangXFPaiNDengCEffects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding densityProg Neuropsychopharmacol Biol Psychiatry201347626823994047
   PubMed Web of Science ®Google Scholar
• LianJHuangXFPaiNDengCChronic betahistine co-treatment reverses olanzapine’s effects on dopamine D2 but not 5-HT2A/2C bindings in rat brainsProg Neuropsychopharmacol Biol Psychiatry201556758025149912
   PubMed Web of Science ®Google Scholar
• PaxinosGWatsonCThe Rat Brain in Stereotaxic Coordinates6th editionLondonElsevier2007
   Google Scholar
• KusumiITakahashiYSuzukiKKamedaKKoyamaTDifferential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brainJ Neural Transm2000107329530210821438
   PubMed Web of Science ®Google Scholar
• TaraziFIZhangKBaldessariniRJLong-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regionsPsychopharmacology2002161326327012021829
   PubMed Web of Science ®Google Scholar
• HuangXFHanMZavitsanouKDengCOlanzapine differently affects 5-HT2a and 2c receptor mRNA expression in the rat brainBehav Brain Res200617135536216716417
   PubMed Web of Science ®Google Scholar
• DeLeonAPatelNCLynn CrismonMAripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerabilityClin Ther200426564966615220010
   PubMed Web of Science ®Google Scholar
• BarnesNMSharpTA review of central 5-HT receptors and their functionNeuropharmacology19993881083115210462127
   PubMed Web of Science ®Google Scholar
• HannonJHoyerDMolecular biology of 5-HT receptorsBehav Brain Res2008195119821318571247
   PubMed Web of Science ®Google Scholar
• MoraPONettoCFGraeffFGRole of 5-HT2A and 5-HT2C receptor subtypes in the two types of fear generated by the elevated T-mazePharmacol Biochem Behav1997584105110579408213
   PubMed Web of Science ®Google Scholar
• BortolozziADíaz-MataixLTothMCeladaPArtigasFIn vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brainPsychopharmacology2007191374575817265076
   PubMed Web of Science ®Google Scholar
• Abi-DarghamALaruelleMAghajanianGKCharneyDKrystalJThe role of serotonin in the pathophysiology and treatment of schizophreniaJ Neuropsychiatry Clin Neurosci1997911179017523
   PubMed Web of Science ®Google Scholar
• BerumenLCRodriguezAMilediRGarcia-AlcocerGSerotonin receptors in hippocampusScientific World Journal2012201215
   Google Scholar
• CorrellCUFrom receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychoticsEur Psychiatry201025suppl 2S12S2120620881
   PubMed Web of Science ®Google Scholar
• KesbyJPCuiXBurneTHJEylesDWAltered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophreniaFront Cell Neurosci2013711123882183
   PubMed Web of Science ®Google Scholar
• KarlTDuffyLO’BrienEMatsumotoIDedovaIBehavioural effects of chronic haloperidol and risperidone treatment in ratsBehav Brain Res2006171228629416697060
   PubMed Web of Science ®Google Scholar
• DunlopBWNemeroffCBThe role of dopamine in the pathophysiology of depressionArch Gen Psychiatry200764332733717339521
   PubMed Web of Science ®Google Scholar
• de OliveiraARReimerAEBrandãoMLRole of dopamine receptors in the ventral tegmental area in conditioned fearBehav Brain Res2009199227127719111792
   PubMed Web of Science ®Google Scholar
• BiojoneCCasarottoPCResstelLBZangrossiHGuimarãesFSMoreiraFAAnti-aversive effects of the atypical antipsychotic, aripiprazole, in animal models of anxietyJ Psychopharmacol201125680180720699351
   PubMed Web of Science ®Google Scholar
• MeltzerHYLiZKanedaYIchikawaJSerotonin receptors: their key role in drugs to treat schizophreniaProg Neuropsychopharmacol Biol Psychiatry20032771159117214642974
   PubMed Web of Science ®Google Scholar
• KlompAVáclavůLMeerhoffGFRenemanLLucassenPJEffects of chronic fluoxetine treatment on neurogenesis and tryptophan hydroxylase expression in adolescent and adult ratsPLoS One201495e9760324827731
   PubMed Web of Science ®Google Scholar
• AndersenSLNavaltaCPAnnual research review: new frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention?J Child Psychol Psychiatry201152447650321309771
   PubMed Web of Science ®Google Scholar
• MazerCMuneyyirciJTahenyKRaioNBorellaAWhitaker-AzmitiaPSerotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficitsBrain Res19977601–268739237519
   PubMed Web of Science ®Google Scholar
• ZhangLMaWBarkerJLRubinowDRSex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosteroneNeuroscience199994125125910613515
   PubMed Web of Science ®Google Scholar
• GogosAKwekPvan den BuuseMThe role of estrogen and testosterone in female rats in behavioral models of relevance to schizophreniaPsychopharmacology2012219121322421800043
   PubMed Web of Science ®Google Scholar
• BetheaCLPecins-ThompsonMSchutzerWEGundlahCLuZNOvarian steroids and serotonin neural functionMol Neurobiol19981828712310065876
   PubMed Web of Science ®Google Scholar
• LadoskyWGaziriLCJBrain serotonin and sexual differentiation of the nervous systemNeuroendocrinology1970631681745425400
   PubMed Web of Science ®Google Scholar
• GogosAKwekPChavezCvan den BuuseMEstrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptorsJ Pharmacol Exp Ther2010333121822720042529
   PubMed Web of Science ®Google Scholar
• CyrMBosséRDi PaoloTGonadal hormones modulate 5-hydroxytryptamine2A receptors: emphasis on the rat frontal cortexNeuroscience19988338298369483566
   PubMed Web of Science ®Google Scholar
• SumnerBEHFinkGEffects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brainMol Cell Neurosci199341839219912911
   PubMedGoogle Scholar
• SumnerBEHFinkGEstrogen increases the density of 5-hydroxytryptamine2a receptors in cerebral cortex and nucleus accumbens in the female ratJ Steroid Biochem Mol Biol1995541–215207632610
   PubMed Web of Science ®Google Scholar
• BorgkvistAMalmlöfTFeltmannKLindskogMSchilströmBDopamine in the hippocampus is cleared by the norepinephrine transporterInt J Neuropsychopharmacol201215453154021669025
   PubMed Web of Science ®Google Scholar
• GuiardBPEl MansariMBlierPCross-talk between dopaminergic and noradrenergic systems in the rat ventral tegmental area, locus ceruleus, and dorsal hippocampusMol Pharmacol20087451463147518703671
   PubMed Web of Science ®Google Scholar
• UzunSKozumplikOMimicaNFolnegovic-SmalcVAripiprazole: an overview of a novel antipsychoticPsychiatr Danub2005171–2677516395846
   PubMedGoogle Scholar